The group's principal activity is to develop, manufacture, sell and market minimally invasive therapies for the treatment of cardiovascular disease. The group's products are the powerlink system and powerweb system, which are catheter-based alternative treatments for abdominal aortic aneurysm. These products are self-expanding stainless steel stent cage is covered by eptfe, a common surgical graft material that reduce the mortality and morbidity rates associated with conventional aaa surgery and provide a clinical alternative patients who could not undergo conventional surgery. The group caters to markets in Europe, Japan and Latin America besides the domestic market.
